Blood Pressure and Other Determinants of New-Onset Atrial Fibrillation in Patients at High Cardiovascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in Ace Intolerant Subjects with Cardiovascular Disease Studies